NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹433 Cr | ₹356 Cr | ₹287 Cr | ₹277 Cr | ₹207 Cr |
What is the latest Total Liabilities ratio of NGL FINECHEM ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹433 Cr |
Mar2024 | ₹356 Cr |
Mar2023 | ₹287 Cr |
Mar2022 | ₹277 Cr |
Mar2021 | ₹207 Cr |
How is Total Liabilities of NGL FINECHEM Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹433 Cr | 21.90 | |
Mar2024 | ₹356 Cr | 23.85 | |
Mar2023 | ₹287 Cr | 3.67 | |
Mar2022 | ₹277 Cr | 33.53 | |
Mar2021 | ₹207 Cr | - |
Compare Total Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹839.8 Cr | -4.7% | -0.9% | -33.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹388,752.0 Cr | 0.7% | -0.7% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,626.0 Cr | 0.6% | -1.9% | 10.9% | Stock Analytics | |
CIPLA | ₹125,951.0 Cr | -0.1% | -0.3% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,932.0 Cr | -1% | -3% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,414.0 Cr | 0.6% | 3.7% | -1.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -4.7% |
-0.9% |
-33.3% |
SENSEX | 1.6% |
2.6% |
-0.3% |
You may also like the below Video Courses